IRD
Opus Genetics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$3.82
−0.52%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 26.50x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- -24.47x
- Price / sales
- 32.25x
- Price / cash flow
- -7.81x
Enterprise value
- Enterprise value
- $263.9M
- EV / sales
- 26.78x
- EV / EBITDA
- -2.52x
- EV / EBIT
- -5.22x
- Market cap
- $317.8M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026